Article

World Cancer Day 2021: The Latest Cancer News and Updates

To honor World Cancer Day 2021, CURE® has rounded up some of the most important 2021 cancer statistics to educate and inform.

Created by the Union for International Cancer Control (UICC) in 2000, World Cancer Day is held every February 4th to raise awareness, improve education and inspire action worldwide, with the goal of creating a world where cancer deaths are prevented, and cancer care is equal for all.

This year’s theme, “I Am and I Will,” is about making a commitment to act and standing up for a cancer-free world.

To honor World Cancer Day 2021, CURE® has rounded up some of the most important 2021 cancer statistics to educate and inform.

World Cancer Day 2021

Cancer Facts & Figures

World Cancer Day 2021

World Cancer Day 2021

  • Going Down: The cancer death rate has fallen 31% from 1991 to 2018. This includes a 2.4% decline from 2017 to 2018 – a new record for the largest one-year drop in the cancer death rate.
  • New Diagnoses: In 2021, almost 1.9 million new cancer cases are expected to be diagnosed in the U.S.
  • Cancer Types: The most common cancers (according to estimated new cases in 2021) are breast cancer, lung cancer, prostate cancer, colorectal cancer, and melanoma of the skin.
  • Increasing Survivorship: There were an estimated 16.9 million cancer survivors in the U.S. as of January 2019. By 2030, this number is projected to top 22.2 million.
  • All in the Family: Between 5% and 10% of all cancers are genetic in nature, meaning they are linked to genes that individuals inherited from their parents.

Data sources: American Cancer Society; National Cancer Institute

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of man.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Related Content